Identification of point mutations in clinical staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1600-1605

  Dean, Melissa A ^a   Olsen, Randall J ^a   Wesley Long, S ^a   Rosato, Adriana E ^a   Musser, James M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; GENTAMICIN; HEMIN; MENADIONE; THYMIDINE;

ABSCESS; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; AUXOTROPHY; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVE SITE; GENE SEQUENCE; GENETIC COMPLEMENTATION; HEMOLYSIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHAGOCYTE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVERTANT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; GENOME, BACTERIAL; GENTAMICINS; MICE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VITAMIN K 3;

EID: 84896472805     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01487-13     Document Type: Article

References (38)

1. Jevons M. 1961. "Celbenin"-resistant staphylococci. Br. Med. J. i:124-125. http://dx.doi.org/10.1136/bmj.1.5219.124-a.
2. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core Surveillance MRSA Investigators. 2007. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763.
3. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, Sentry Participants Group. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl 2):S114-S132. http://dx.doi.org/10.1086/320184.
4. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis. 197:1226-1234. http://dx.doi.org/10.1086/533494.
5. von Eiff C, Becker K, Machka K, Stammer H, Peters G. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16. http://dx.doi.org/10.1056/NEJM200101043440102.
6. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, Proctor RA, Peters G. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:1023-1029. http://dx.doi.org/10.1086/515238.
7. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102. http://dx.doi.org/10.1093/clinids/20.1.95.
8. von Eiff C, Vaudaux P, Kahl BC, Lew D, Emler S, Schmidt A, Peters G, Proctor RA. 1999. Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin. Infect. Dis. 29:932-934. http://dx.doi.org/10.1086/520462.
9. Proctor RA, Peters G. 1998. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin. Infect. Dis. 27: 419-422. http://dx.doi.org/10.1086/514706.
10. McNamara PJ, Proctor RA. 2000. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int. J. Antimicrob. Agents 14:117-122. http://dx.doi.org/10.1016/S0924-8579(99)00170-3.
11. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295-305. http://dx.doi.org/10.1038/nrmicro1384.
12. Sendi P, Proctor RA. 2009. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 17:54-58. http://dx.doi.org/10.1016/j.tim.2008.11.004.
13. Melter O, Radojevic B. 2010. Small colony variants of Staphylococcus aureus-review. Folia Microbiol. (Praha) 55:548-558. http://dx.doi.org/10.1007/s12223-010-0089-3.
14. Kahl B, von Eiff C, Hermann M, Peters G, Proctor RA. 1996. Staphylococcal small colony variants present a challenge to clinicians and clinical microbiologists. Antimicrob. Infect. Dis. Newsl. 15:59-63. http://dx.doi.org/10.1016/S1069-417X(00)80009-6.
15. Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, Denis O, Tulkens PM, Van Bambeke F. 2013. Antibiotic activity against smallcolony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J. Antimicrob. Chemother. 68:1455-1464. http://dx.doi.org/10.1093/jac/dkt072.
16. Fang M, Macova A, Hanson KL, Kos J, Palmer DR. 2011. Using substrate analogues to probe the kinetic mechanism and active site of Escherichia coli MenD. Biochemistry 50:8712-8721. http://dx.doi.org/10.1021/bi201202n.
17. Lannergard J, von Eiff C, Sander G, Cordes T, Seggewiss J, Peters G, Proctor RA, Becker K, Hughes D. 2008. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:4017-4022. http://dx.doi.org/10.1128/AAC.00668-08.
18. Lu X, Zhang H, Tonge PJ, Tan DS. 2008. Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis. Bioorg. Med. Chem. Lett. 18:5963-5966. http://dx.doi.org/10.1016/j.bmcl.2008.07.130.
19. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
20. Shea PR, Beres SB, Flores AR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Ayers SD, Webb P, Willey BM, Low DE, Musser JM. 2011. Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc. Natl. Acad. Sci. U. S. A. 108:5039-5044. http://dx.doi.org/10.1073/pnas.1016282108.
21. Hartas J, Hibble M, Sriprakash KS. 1998. Simplification of a locusspecific DNA typing method (Vir typing) for Streptococcus pyogenes. J. Clin. Microbiol. 36:1428-1429.
22. Finan JE, Rosato AE, Dickinson TM, Ko D, Archer GL. 2002. Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob. Agents Chemother. 46:24-30. http://dx.doi.org/10.1128/AAC.46.1.24-30.2002.
23. Bernheimer AW. 1988. Assay of hemolytic toxins. Methods Enzymol. 165:213-217. http://dx.doi.org/10.1016/S0076-6879(88)65033-6.
24. Balwit JM, van Langevelde P, Vann JM, Proctor RA. 1994. Gentamicinresistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037. http://dx.doi.org/10.1093/infdis/170.4.1033.
25. von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25:1250-1251. http://dx.doi.org/10.1086/516962.
26. Maple PA, Hamilton-Miller JM, Brumfitt W. 1991. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 35:345-350. http://dx.doi.org/10.1128/AAC.35.2.345.
27. Schmitz FJ, Fluit AC, Hafner D, Beeck A, Perdikouli M, Boos M, Scheuring S, Verhoef J, Kohrer K, Von Eiff C. 2000. Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillinsusceptible and-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 44:3229-3231. http://dx.doi.org/10.1128/AAC.44.11.3229-3231.2000.
28. Thompson TB, Garrett JB, Taylor EA, Meganathan R, Gerlt JA, Rayment I. 2000. Evolution of enzymatic activity in the enolase superfamily: structure of o-succinylbenzoate synthase from Escherichia coli in complex with Mg2+ and o-succinylbenzoate. Biochemistry 39:10662-10676. http://dx.doi.org/10.1021/bi000855o.
29. Gulick AM, Starai VJ, Horswill AR, Homick KM, Escalante-Semerena JC. 2003. The 1.75 A crystal structure of acetyl-CoA synthetase bound to adenosine-5'-propylphosphate and coenzyme A. Biochemistry 42:2866-2873. http://dx.doi.org/10.1021/bi0271603.
30. von Eiff C. 2008. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int. J. Antimicrob. Agents 31:507-510. http://dx.doi.org/10.1016/j.ijantimicag.2007.10.026.
31. Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP, Peters G. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27(Suppl 1):S68-S74.
32. von Eiff C, Peters G, Becker K. 2006. The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 37(Suppl 2):S26-S33. http://dx.doi.org/10.1016/j.injury.2006.04.006.
33. Proctor RA, Balwit JM, Vesga O. 1994. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 3:302-312.
34. Kurosu M, Narayanasamy P, Biswas K, Dhiman R, Crick DC. 2007. Discovery of 1,4-dihydroxy-2-naphthoate prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens. J. Med. Chem. 50:3973-3975. http://dx.doi.org/10.1021/jm070638m.
35. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Gotz F. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.
36. Kurosu M, Crick DC. 2009. MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis. Med. Chem. 5:197-207. http://dx.doi.org/10.2174/157340609787582882.
37. Debnath J, Siricilla S, Wan B, Crick DC, Lenaerts AJ, Franzblau SG, Kurosu M. 2012. Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis. J. Med. Chem. 55:3739-3755. http://dx.doi.org/10.1021/jm201608g.
38. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6:29-40. http://dx.doi.org/10.1038/nrd2201.